United Asset Strategies’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-500
| Closed | -$322K | – | 206 |
|
|
2021
Q2 | $322K | Sell |
500
-100
| -17% | -$64.4K | 0.04% | 173 |
|
|
2021
Q1 | $343K | Sell |
600
-130
| -18% | -$74.3K | 0.05% | 168 |
|
|
2020
Q4 | $426K | Hold |
730
| – | – | 0.07% | 151 |
|
|
2020
Q3 | $376K | Hold |
730
| – | – | 0.07% | 154 |
|
|
2020
Q2 | $330K | Hold |
730
| – | – | 0.07% | 146 |
|
|
2020
Q1 | $256K | Sell |
730
-120
| -14% | -$42.1K | 0.06% | 154 |
|
|
2019
Q4 | $315K | Hold |
850
| – | – | 0.06% | 168 |
|
|
2019
Q3 | $283K | Hold |
850
| – | – | 0.06% | 156 |
|
|
2019
Q2 | $266K | Sell |
850
-500
| -37% | -$156K | 0.06% | 162 |
|
|
2019
Q1 | $413K | Sell |
1,350
-50
| -4% | -$15.3K | 0.1% | 152 |
|
|
2018
Q4 | $325K | Hold |
1,400
| – | – | 0.09% | 149 |
|
|
2018
Q3 | $438K | Sell |
1,400
-25
| -2% | -$7.82K | 0.1% | 149 |
|
|
2018
Q2 | $411K | Hold |
1,425
| – | – | 0.11% | 157 |
|
|
2018
Q1 | $356K | Hold |
1,425
| – | – | 0.11% | 154 |
|
|
2017
Q4 | $340K | Buy |
+1,425
| New | +$340K | 0.09% | 154 |
|